ACTIVISM ALERT Dr. Steven Brem joins the Musella Foundation as Chief Scientific Advisor!
FDA APPROVAL ALERTModeyso™ (Onc-201) approved for Recurrent H3K27M-mutant Diffuse Midline Glioma
Our next webinar will be on Sept 18, 2025 at 7pm Eastern. Click here for details
Officers and Medical Advisory Board


Our privacy / cookie policy has changed.
Click HERE to read it!